|
Volumn 1, Issue 7, 2012, Pages 1181-1182
|
Interleukin-2 treatment of tumor patients can expand regulatory T cells
|
Author keywords
Immunotherapy; Interleukin 2; Treg cells; Tumor
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYTOKINE;
INTERLEUKIN 2;
T LYMPHOCYTE RECEPTOR;
TRANSCRIPTION FACTOR FOXP3;
ARTICLE;
AUTOIMMUNITY;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER PATIENT;
CANCER STAGING;
CD4+ T LYMPHOCYTE;
CD8+ T LYMPHOCYTE;
CELL EXPANSION;
COLORECTAL CANCER;
DRUG SAFETY;
EFFECTOR CELL;
HUMAN;
IMMUNE DEFICIENCY;
IMMUNOLOGICAL TOLERANCE;
LYMPHOCYTE PROLIFERATION;
MEMORY T LYMPHOCYTE;
MONOTHERAPY;
NONHUMAN;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REGULATORY T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
TUMOR IMMUNOLOGY;
TUMOR MICROENVIRONMENT;
|
EID: 84883553471
PISSN: 21624011
EISSN: 2162402X
Source Type: Journal
DOI: 10.4161/onci.20639 Document Type: Article |
Times cited : (12)
|
References (10)
|